Abstract
INTRODUCTION: Although fecal microbiota transplantation (FMT) is a recommended, clinically efficacious, and cost-effective treatment for recurrent Clostridioides difficile infection (CDI), the scale of FMT use in the United States is unknown. METHODS: We developed a population-level CDI model. RESULTS: We estimated that 48,000 FMTs could be performed annually, preventing 32,000 CDI recurrences. DISCUSSION: Improving access to FMT could lead to tens of thousands fewer C. difficile episodes per year.
Cite
CITATION STYLE
Mamoon, L., & Olesen, S. W. (2020). Fecal Microbiota Transplants Annually and Their Positive Clinical Impact. Clinical and Translational Gastroenterology, 11(11), e00247. https://doi.org/10.14309/ctg.0000000000000247
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.